The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Chiron Corporation

Chiron Corporation
Nasdaq: CHIR
Change
symbol:
     
 NEWS FROM THE WIRES
U.S. FDA raps Aventis, SkyePharma over drug claims
Aug 07 2001 09:13 AM PDT

Chiron Q2 profits dip, 2001 outlook raised
Jul 25 2001 01:17 PM PDT

Australian stocks dragged lower by miners, CPI
Jul 24 2001 11:39 PM PDT

SkyePharma licenses cancer drug to Elan
Jul 24 2001 11:38 PM PDT

Chiron sells meningitis vaccine to Quebec, shrs up
Jul 18 2001 09:24 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
Planes, Loans and Automobiles
Nov 20 2000 12:00 AM PST

DNA Detectives
May 22 2000 12:00 AM PDT

Posts
Apr 17 2000 12:00 AM PDT

 PROFILE
Chiron doesn't horse around when it comes to health. Named for a half-man/half-horse character from Greek mythology, Chiron focuses on developing biopharmaceuticals, vaccines, and blood testing devices. Its products target such diseases as AIDS, hepatitis, cardiovascular disease, and cancer. The company's flagship product, Proleukin, fights renal cancer and melanoma. Chiron makes most of its money from sales and licensing of existing products but is looking for its next blockbuster. The firm is working with Pharmacia to develop the first treatment for the potentially fatal infection sepsis. Novartis owns about 40% of the company.

 COMPETITION
Abbott Laboratories (ABT)
Amgen Inc. (AMGN)
Merck & Co., Inc. (MRK)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 972.10
1-Yr. Sales Growth: 27.5%
Employees: 3,422
Revenue per employee: $284,073.64

 KEY PEOPLE
• Sean P. Lance
    CEO
• James R. Sulat
    CFO

 CONTACT INFO
4560 Horton St.
Emeryville, CA 94608
US
Phone: 510-655-8730
Fax: 510-655-9910
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001